These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 31298938)

  • 41. Primary care cohort study in the sequence of diagnosing chronic respiratory diseases and prescribing inhaled corticosteroids.
    Geraets I; Schermer T; Kocks JWH; Akkermans R; Bischoff E; van den Bemt L
    NPJ Prim Care Respir Med; 2018 Oct; 28(1):37. PubMed ID: 30301889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
    Aveyard P; Gao M; Lindson N; Hartmann-Boyce J; Watkinson P; Young D; Coupland CAC; Tan PS; Clift AK; Harrison D; Gould DW; Pavord ID; Hippisley-Cox J
    Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dose of inhaled corticosteroids in patients with COPD: when less is better.
    Izquierdo JL; Cosio BG
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3539-3547. PubMed ID: 30498343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
    Sonnappa S; Martin R; Israel E; Postma D; van Aalderen W; Burden A; Usmani OS; Price DB;
    PLoS One; 2017; 12(6):e0178112. PubMed ID: 28617814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhaled Corticosteroid-Related Tuberculosis in the Real World Among Patients with Asthma and COPD: A 10-Year Nationwide Population-Based Study.
    Lee CM; Heo J; Han SS; Moon KW; Lee SH; Kim YJ; Lee SJ; Kwon JW
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1197-1206.e3. PubMed ID: 30339858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.
    Yawn BP; Li Y; Tian H; Zhang J; Arcona S; Kahler KH
    Int J Chron Obstruct Pulmon Dis; 2013; 8():295-304. PubMed ID: 23836970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder.
    Chen S; Plauschinat CA; Wu N; Fraser K; Boulanger L
    J Med Econ; 2011; 14(4):458-62. PubMed ID: 21651427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Ann Pharmacother; 2017 Nov; 51(11):945-953. PubMed ID: 28677404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study.
    Heerfordt CK; Rønn C; Harboe ZB; Ingebrigtsen TS; Svorre Jordan A; Wilcke JT; Bonnesen B; Biering-Sørensen T; Sørensen R; Holler JG; Itenov TS; Johansen HK; Sivapalan P; Eklöf J; Jensen JS
    BMJ Open Respir Res; 2023 Sep; 10(1):. PubMed ID: 37775111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan.
    Hirano R; Fujita M; Matsumoto T; On R; Watanabe K
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3503-3509. PubMed ID: 30498340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risks of pneumonia in patients with asthma taking inhaled corticosteroids.
    O'Byrne PM; Pedersen S; Carlsson LG; Radner F; Thorén A; Peterson S; Ernst P; Suissa S
    Am J Respir Crit Care Med; 2011 Mar; 183(5):589-95. PubMed ID: 20889908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of a history of asthma on long-term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study.
    Kendzerska T; To TM; Aaron SD; Lougheed MD; Sadatsafavi M; FitzGerald JM; Gershon AS;
    J Allergy Clin Immunol; 2017 Mar; 139(3):835-843. PubMed ID: 27641119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease.
    Vozoris NT; Wang X; Austin PC; O'Donnell DE; Aaron SD; To TM; Gershon AS
    Br J Clin Pharmacol; 2018 Mar; 84(3):579-589. PubMed ID: 29139564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT].
    Morros R; Vedia C; Giner-Soriano M; Casellas A; Amado E; Baena JM;
    Aten Primaria; 2019; 51(6):333-340. PubMed ID: 29661670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.
    O'Byrne PM; Rennard S; Gerstein H; Radner F; Peterson S; Lindberg B; Carlsson LG; Sin DD
    Respir Med; 2012 Nov; 106(11):1487-93. PubMed ID: 22902134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study.
    Liu SF; Kuo HC; Lin MC; Ho SC; Tu ML; Chen YM; Chen YC; Fang WF; Wang CC; Liu GH
    Oncotarget; 2017 May; 8(18):29711-29721. PubMed ID: 28412726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.